Abstract Details

Title Idebenone Is Effective and Well Tolerated in Leber’s Hereditary Optic Neuropathy (LHON): Results of a 3-Year Expanded Access Program

Topic Neuro-ophthalmology/Neuro-otology

Presentation(s) (-)

Poster/Presentation
Number 005

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Thomas H. Klopstock, MD (University of Munich, Dept. of Neurology) PRESENTER	Dr. Klopstock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GenSight Biologics. Dr. Klopstock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chiesi GmbH. Dr. Klopstock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi GmbH. Dr. Klopstock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chiesi GmbH. Dr. Klopstock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GenSight Biologics.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Thomas Meier, PhD (Santhera Pharmaceuticals)	No disclosure on file
Claudia Catarino	No disclosure on file

��ɫ��